
1444: Lawful but Awful
Moderna Bivalent Booster, Chronic COVID Immune Issues
Moderna is developing a new "bivalent" booster shot designed to target both the original COVID-19 strain and the Beta variant. The hosts discuss reports of rising hepatitis cases and "AIDS-like" immune system degradation in highly vaccinated populations like Australia and New Zealand. They express skepticism regarding the long-term safety of mRNA technology.

